India's First MRNA COVID-19 Vaccine Candidate Approved To Start Phase II, III Trials

[email protected]27 Sep, 2021News

The Indian drug regulator, the Drugs Controller General of India (DCGI), on Tuesday granted approval for phase II and III clinical trials of the country's first mRNA COVID-19 vaccine candidate ? HGCO19, officials said. The vaccine is being developed by Gennova Biopharmaceuticals in partnership with the department of biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) under the mission COVID-19 suraksha (protection).